As I said, there are many different ways to skin a cat. The way Canada implemented the waiver is not the only way to implement. That's clear. Other countries have waived certain things. They've waived the voluntary licence requirement in instances of national emergency or extreme emergency. We haven't done that. Other countries don't have pre-approved lists of drugs in eligible importing countries. In my mind, speaking as an expert in the patent field, that's an advantage to our regime, not a disadvantage. Having a pre-approved list makes it a lot easier for the patent authority to figure out whether they can grant a licence or not, and it minimizes the opportunity to litigate that decision.
Obviously, one of the options before us at this point is to consider harmonizing ourselves more closely with these other countries that have implemented in a somewhat different way. But the fact remains that those regimes haven't given rise to any exports either.
So whatever the problem is, it's a shared problem among all the implementing countries. I don't think Canada has singled itself out or stigmatized itself in the way that you suggest.